BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Carisma Therapeutics Inc. (Nasdaq - CARM), Guaranty Bancshares, Inc. (NYSE - GNTY), MRC Global Inc. (NYSE - MRC), Turnstone Biologics Corp. (Nasdaq - TSBX)

Stock Information for Turnstone Biologics Corp.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Turnstone Biologics Corp.

ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction
Turnstone Biologics Corp. Enters into Agreement to be Acquired by XOMA Royalty Corporation for $0.34 in Cash Per Share Plus a Contingent Value Right
XOMA Royalty Declares Quarterly Preferred Stock Dividends
XOMA Royalty Purchases Mezagitamab Royalty and Milestone Rights Held by BioInvent International for up to USD $30 Million
XOMA Royalty Reports First Quarter 2025 Financial Results and Highlights Business Achievements
XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference
XOMA Royalty Completes Sale of Kinnate Pipeline Assets
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.